These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 34703256)
21. Regulation of ANGPTL8 in liver and adipose tissue by nutritional and hormonal signals and its effect on glucose homeostasis in mice. Zhang L; Shannon CE; Bakewell TM; Abdul-Ghani MA; Fourcaudot M; Norton L Am J Physiol Endocrinol Metab; 2020 May; 318(5):E613-E624. PubMed ID: 32154742 [TBL] [Abstract][Full Text] [Related]
23. ANGPTL8 in metabolic homeostasis: more friend than foe? Guo C; Wang C; Deng X; He J; Yang L; Yuan G Open Biol; 2021 Sep; 11(9):210106. PubMed ID: 34582711 [TBL] [Abstract][Full Text] [Related]
24. Circulating Betatrophin Correlates with Triglycerides and Postprandial Glucose among Different Glucose Tolerance Statuses--A Case-Control Study. Gao T; Jin K; Chen P; Jin H; Yang L; Xie X; Yang M; Hu C; Yu X PLoS One; 2015; 10(8):e0133640. PubMed ID: 26247824 [TBL] [Abstract][Full Text] [Related]
25. Angiopoietin-like protein 8 (betatrophin) may inhibit hepatocellular carcinoma through suppressing of the Wnt signaling pathway. Monzavi N; Zargar SJ; Gheibi N; Azad M; Rahmani B Iran J Basic Med Sci; 2019 Oct; 22(10):1166-1171. PubMed ID: 31998458 [TBL] [Abstract][Full Text] [Related]
26. Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome. Abu-Farha M; Abubaker J; Al-Khairi I; Cherian P; Noronha F; Kavalakatt S; Khadir A; Behbehani K; Alarouj M; Bennakhi A; Elkum N Cardiovasc Diabetol; 2016 Feb; 15():25. PubMed ID: 26850725 [TBL] [Abstract][Full Text] [Related]
27. The Effects of Serum ANGPTL8/betatrophin on the Risk of Developing the Metabolic Syndrome - A Prospective Study. Wang H; Lai Y; Han C; Liu A; Fan C; Wang H; Zhang H; Ding S; Teng W; Shan Z Sci Rep; 2016 Jun; 6():28431. PubMed ID: 27345212 [TBL] [Abstract][Full Text] [Related]
28. Investigation of the relationship between betatrophin and certain key enzymes involved in carbohydrate and lipid metabolism in insulin-resistant mice. Arikan FB; Ulas M; Ustundag Y; Boyunaga H; Badem ND Horm Mol Biol Clin Investig; 2023 Sep; 44(3):311-320. PubMed ID: 36869875 [TBL] [Abstract][Full Text] [Related]
29. Angiopoietin-like 8 (ANGPTL8) expression is regulated by miR-143-3p in human hepatocytes. DiStefano JK Gene; 2019 Jan; 681():1-6. PubMed ID: 30261196 [TBL] [Abstract][Full Text] [Related]
30. Relationship between serum betatrophin levels and the first-phase of glucose-stimulated insulin secretion. Liu D; Qu H; Wang H; Duan Y; Liu F; Feng Z; Deng H Obes Res Clin Pract; 2018; 12(Suppl 2):9-15. PubMed ID: 27554132 [TBL] [Abstract][Full Text] [Related]
31. Associations of betatrophin levels with irisin in Chinese women with normal glucose tolerance. Xie X; Gao T; Yang M; Chen P; Jin H; Yang L; Yu X Diabetol Metab Syndr; 2015; 7():26. PubMed ID: 25859278 [TBL] [Abstract][Full Text] [Related]
32. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Fenzl A; Itariu BK; Kosi L; Fritzer-Szekeres M; Kautzky-Willer A; Stulnig TM; Kiefer FW Diabetologia; 2014 Jun; 57(6):1204-8. PubMed ID: 24623100 [TBL] [Abstract][Full Text] [Related]
33. Circulating angiopoietin-like protein 8 is independently associated with fasting plasma glucose and type 2 diabetes mellitus. Ebert T; Kralisch S; Hoffmann A; Bachmann A; Lössner U; Kratzsch J; Blüher M; Stumvoll M; Tönjes A; Fasshauer M J Clin Endocrinol Metab; 2014 Dec; 99(12):E2510-7. PubMed ID: 25325797 [TBL] [Abstract][Full Text] [Related]
34. Recombinant betatrophin (Angptl‑8/lipasin) ameliorates streptozotocin‑induced hyperglycemia and β‑cell destruction in neonatal rats. Zhang D; Yu YJ; Xu FS; Yuan JH; Wang R; Zhang CS; Wang LX; Liu Y; Song LM; Liu JL; Dong J Mol Med Rep; 2019 Nov; 20(5):4523-4532. PubMed ID: 31702044 [TBL] [Abstract][Full Text] [Related]
35. Visualizing the regulatory role of Angiopoietin-like protein 8 (ANGPTL8) in glucose and lipid metabolic pathways. Siddiqa A; Cirillo E; Tareen SHK; Ali A; Kutmon M; Eijssen LMT; Ahmad J; Evelo CT; Coort SL Genomics; 2017 Oct; 109(5-6):408-418. PubMed ID: 28684091 [TBL] [Abstract][Full Text] [Related]
36. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome. Fu J; Hou C; Li L; Feng D; Li G; Li M; Li C; Gao S; Li M Cardiovasc Diabetol; 2016 Oct; 15(1):142. PubMed ID: 27716289 [TBL] [Abstract][Full Text] [Related]
37. ANGPTL8/Betatrophin R59W variant is associated with higher glucose level in non-diabetic Arabs living in Kuwaits. Abu-Farha M; Melhem M; Abubaker J; Behbehani K; Alsmadi O; Elkum N Lipids Health Dis; 2016 Feb; 15():26. PubMed ID: 26864934 [TBL] [Abstract][Full Text] [Related]
38. Role of Betatrophin and Inflammation Markers in Type 2 Diabetes Mellitus, Prediabetes and Metabolic Syndrome. Onalan E; Bozkurt A; Gursu MF; Yakar B; Donder E J Coll Physicians Surg Pak; 2022 Mar; 32(3):303-307. PubMed ID: 35148580 [TBL] [Abstract][Full Text] [Related]
39. Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus. Trebotic LK; Klimek P; Thomas A; Fenzl A; Leitner K; Springer S; Kiefer FW; Kautzky-Willer A PLoS One; 2015; 10(9):e0136701. PubMed ID: 26325425 [TBL] [Abstract][Full Text] [Related]
40. Circulating betatrophin in healthy control and type 2 diabetic subjects and its association with metabolic parameters. Al-Daghri NM; Rahman S; Sabico S; Amer OE; Wani K; Ansari MG; Al-Attas OS; Kumar S; Alokail MS J Diabetes Complications; 2016; 30(7):1321-5. PubMed ID: 27311786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]